亚宝药业: 亚宝药业2024年年度股东大会法律意见书

Group 1 - The legal opinion letter confirms that the 2024 annual general meeting of shareholders for Yabao Pharmaceutical Group Co., Ltd. was convened and conducted in accordance with relevant laws and regulations [4][9] - The meeting was scheduled for May 16, 2025, and was announced on April 26, 2025, with all necessary documentation provided [5][6] - The meeting was attended by 4 shareholders in person, representing 63,988,100 shares, and 367 participants voted online, representing 169,190,891 shares, which accounted for 24.1701% of the total shares [7] Group 2 - The qualifications of attendees included all shareholders registered by May 9, 2025, along with directors, supervisors, senior management, and invited guests [6][7] - No new proposals were submitted by shareholders during the meeting [8] - Voting was conducted through both in-person and online methods, with results confirming that all resolutions passed met the required majority [8][9]